Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.21
0.00 (-0.10%)
At close: May 30, 2025, 4:00 PM
5.21
0.00 (0.10%)
After-hours: May 30, 2025, 4:00 PM EDT
Third Harmonic Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Third Harmonic Bio stock have an average target of 5.00, which predicts a -3.94% decrease from the current stock price of 5.21.
Price Target: $5.00 (-3.94%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 28, 2025.
Analyst Ratings
The average analyst rating for Third Harmonic Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy → Hold Downgrades $23 → $5 | Strong Buy → Hold | Downgrades | $23 → $5 | -3.94% | Mar 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $20 → $5 | Buy → Hold | Downgrades | $20 → $5 | -3.94% | Feb 12, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $12 → $20 | Hold → Buy | Upgrades | $12 → $20 | +284.25% | Aug 9, 2024 |
| Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +341.88% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.89
from -1.09
EPS Next Year
-1.00
from -0.89
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.89 | -1.00 | -1.00 | ||
| Avg | -0.89 | -1.00 | -1.21 | ||
| Low | -0.87 | -0.99 | -1.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.